Jay Lee

Jay Lee is a senior equity analyst, healthcare, for Morningstar. He covers global biopharma companies and life science tools and diagnostics companies.

Before joining Morningstar in 2017, Lee was an executive director and Asia head of mortgage products at Goldman Sachs, where he spent 11 years working on trading desks in New York, Tokyo, and Hong Kong. At Morningstar, he spent five years in Hong Kong covering Chinese and Japanese healthcare companies, including large drugmakers, biotech companies, and contract development and manufacturing organizations, before transferring to Chicago in 2023.

Lee holds a bachelor’s degree in mathematics from Brown University, where he graduated magna cum laude, and is a member of Phi Beta Kappa.